Anti-IL-12 or interferon-γ-specific antibodies antagonize the development of spontaneous IBD in IL-10-deficient mice, but only neutralization of IL-12 ameliorated the disease [4]. This evidence concerns the gene IL10 and inflammatory bowel disease.